Susquehanna International Group’s NeoGenomics NEO Stock Holding History

Susquehanna International Group’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$352K	Buy	47,452 +33,082	+230%	+$348K	﹤0.01%	10518
2025 Q4	$169K	Sell	14,370 -1,949	-12%	-$21K	﹤0.01%	11054
2025 Q3	$126K	Sell	16,319 -164,708	-91%	-$1.15M	﹤0.01%	11414
2025 Q2	$1.32M	Sell	181,027 -12,622	-7%	-$102K	﹤0.01%	6737
2025 Q1	$1.84M	Buy	193,649 +124,080	+178%	+$1.55M	﹤0.01%	5713
2024 Q4	$1.15M	Buy	69,569 +40,822	+142%	+$634K	﹤0.01%	6616
2024 Q3	$424K	Sell	28,747 -8,820	-23%	-$138K	﹤0.01%	8867
2024 Q2	$521K	Buy	+37,567	New	+$533K	﹤0.01%	8166
2024 Q1	–	Sell	-74,339	Closed	-$1.15M	–	12937
2023 Q4	$1.2M	Buy	74,339 +25,256	+51%	+$413K	﹤0.01%	6532
2023 Q3	$604K	Sell	49,083 -34,564	-41%	-$514K	﹤0.01%	7784
2023 Q2	$1.34M	Sell	83,647 -120,701	-59%	-$1.99M	﹤0.01%	6007
2023 Q1	$3.56M	Buy	204,348 +155,123	+315%	+$2.21M	﹤0.01%	3980
2022 Q4	$455K	Sell	49,225 -104,526	-68%	-$974K	﹤0.01%	8117
2022 Q3	$1.32M	Sell	153,751 -61,491	-29%	-$611K	﹤0.01%	5907
2022 Q2	$1.75M	Buy	+215,242	New	+$2.05M	﹤0.01%	5191
2022 Q1	–	Sell	-70,940	Closed	-$1.49M	–	13637
2021 Q4	$2.42M	Sell	70,940 -3,840	-5%	-$150K	﹤0.01%	5068
2021 Q3	$3.61M	Buy	74,780 +54,484	+268%	+$2.52M	﹤0.01%	4571
2021 Q2	$917K	Sell	20,296 -56,630	-74%	-$2.51M	﹤0.01%	8009
2021 Q1	$3.71M	Sell	76,926 -20,219	-21%	-$1.05M	﹤0.01%	4504
2020 Q4	$5.23M	Buy	97,145 +77,623	+398%	+$3.51M	﹤0.01%	3353
2020 Q3	$720K	Sell	19,522 -20,659	-51%	-$768K	﹤0.01%	6906
2020 Q2	$1.25M	Sell	40,181 -29,895	-43%	-$828K	﹤0.01%	5420
2020 Q1	$1.94M	Sell	70,076 -51,210	-42%	-$1.53M	﹤0.01%	4026
2019 Q4	$3.55M	Sell	121,286 -51,123	-30%	-$1.22M	﹤0.01%	3448
2019 Q3	$3.3M	Buy	172,409 +62,299	+57%	+$1.46M	﹤0.01%	3343
2019 Q2	$2.42M	Buy	+110,110	New	+$2.42M	﹤0.01%	3809
2019 Q1	–	Sell	-57,407	Closed	-$998K	–	9494
2018 Q4	$724K	Buy	+57,407	New	+$856K	﹤0.01%	5322
2018 Q3	–	Sell	-57,972	Closed	-$801K	–	9899
2018 Q2	$760K	Buy	+57,972	New	+$638K	﹤0.01%	5953
2017 Q3	–	Sell	-45,807	Closed	-$446K	–	9351
2017 Q2	$410K	Buy	45,807 +33,207	+264%	+$264K	﹤0.01%	7002
2017 Q1	$99K	Sell	12,600 -90,699	-88%	-$739K	﹤0.01%	8395
2016 Q4	$885K	Buy	103,299 +51,699	+100%	+$443K	﹤0.01%	5791
2016 Q3	$424K	Buy	51,600 +1,817	+4%	+$15.2K	﹤0.01%	6361
2016 Q2	$400K	Buy	+49,783	New	+$399K	﹤0.01%	6496
2015 Q2	–	Sell	-85,745	Closed	-$442K	–	10323
2015 Q1	$400K	Buy	85,745 +73,901	+624%	+$321K	﹤0.01%	7498
2014 Q4	$49K	Buy	+11,844	New	+$54.4K	﹤0.01%	9369
2014 Q3	–	Sell	-32,206	Closed	-$165K	–	9751
2014 Q2	$107K	Buy	+32,206	New	+$107K	﹤0.01%	9403
2014 Q1	–	Sell	-14,748	Closed	-$55.3K	–	9249
2013 Q4	$53K	Buy	+14,748	New	+$51.2K	﹤0.01%	8785

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Susquehanna International Group's NEO Position: Q1 2026 in Review

Susquehanna International Group increased its NeoGenomics (NEO) stake by 230% in Q1 2026, buying an estimated $348K and bringing the position to 47,452 shares worth $352K. The position accounts for ﹤0.01% of the portfolio, ranked #10518.

Susquehanna International Group first reported a position in NEO in Q4 2013 and has held it in 37 quarters since. The position peaked at $5.23M in Q4 2020. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

Susquehanna International Group held 47,452 shares of NeoGenomics worth $352K as of Q1 2026.
Susquehanna International Group bought 33,082 NeoGenomics shares in Q1 2026, an estimated $348K.
NeoGenomics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10518 holding.
Susquehanna International Group first reported a position in NeoGenomics in Q4 2013 and has held it in 37 quarters since.
Susquehanna International Group's NeoGenomics position peaked at $5.23M in Q4 2020.
253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.